Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura

✍ Scribed by George A. Stouffer; Jana Hirmerova; Stephan Moll; Bryon Rubery; Mark Napoli; E. Magnus Ohman; Ross Simpson

• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 142 KB
• Volume: 61
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.10799

✦ Synopsis

Abstract

The appropriate regimen of platelet inhibitors that should be used in patients with immune thrombocytopenia purpura (ITP; formerly called idiopathic thrombocytopenic purpura) who are undergoing percutaneous coronary intervention is unclear. We report the case of a patient with ITP who underwent two separate coronary interventions. The first involved the use of aspirin and a cutting balloon to treat obstructive disease of the left circumflex. When the patient presented with restenosis, he received eptifibatide, clopidogrel, and an intracoronary stent. He is currently 16 months removed from his second procedure and remains physically active without any anginal symptoms. Percutaneous revascularization in patients with ITP remains a challenge and this therapeutic approach, while ultimately successful in the patient, requires further validation. Catheter Cardiovasc Interv 2004;61:364–367. © 2004 Wiley‐Liss, Inc.